Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis

Firoozeh Sahebi, MD, Simona Iacobelli, Ph. D., Anja Van Biezen, Liisa Volin, MD, Peter Dreger, Mauricette Michallet, MD, PhD, Per T. Ljungman, MD, PhD, Goesta Gahrton, MD, PhD, Curly TCM Morris, MD, Stefan Schonland, Theo de Witte, MD, Laurent Garderet, MD, Nicolaus Kroeger, MD, Anja Henseler, Nicolaas PM Schaap, MD, PhD, D Caballero, Xavier Poire, MD, Jakob Passweg, Rose-Marie Hamljadi

Blood (2013) 122 (21): 920.

https://doi.org/10.1182/blood.V122.21.920.920

Published: 2013

Journal Articles

The Roel of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In PATIENTS with POEMS SYNDROME: A Retrospective study of the MM Subcommittee of the Chronic Leukemia Working Party of the EBMT,

Gordon Cook, Laurent Garderet, MD, Anja van Biezen, Anja Henseler, MSc, Véronique Leblond, MD, PhD, M Rovira, Dominique Bordessoule, Giuseppe Leone, Gert J Ossenkoppele, MD, PhD, Jenny Byrne, MD, PhD, Mark Cook, D Caballero, Theo M. de Witte, MD, Curly TCM Morris, MD

Blood (2011) 118 (21): 4115.

https://doi.org/10.1182/blood.V118.21.4115.4115

Published: 2011

Journal Articles

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Blood (2009) 114 (1): 148–152.

https://doi.org/10.1182/blood-2008-11-187724

Published: 2009

Journal Articles

R-ESHAP as Salvage Therapy for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Spanish GEL-TAMO Multicenter Study.

Blood (2007) 110 (11): 3438.

https://doi.org/10.1182/blood.V110.11.3438.3438

Published: 2007

Journal Articles

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Miguel A. Canales, A. Salar, J.A. Diaz, J.J. Ferreiro, S. Ferrer, A. Llorente, D. Caballero, J.A. Garcia-Marco, L. Palomera, J.J. Sanchez-Blanco, E. Gonzalez-Barca

Blood (2007) 110 (11): 4459.

https://doi.org/10.1182/blood.V110.11.4459.4459

Published: 2007

Journal Articles

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Diffuse Large-B Cell Lymphoma (DLBCL): A Spanish Multicenter Study.

Blood (2005) 106 (11): 2457.

https://doi.org/10.1182/blood.V106.11.2457.2457

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation and Rituximab for Mantle Cell Lymphoma.

Blood (2005) 106 (11): 2092.

https://doi.org/10.1182/blood.V106.11.2092.2092

Published: 2005

Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon

Blood (2004) 104 (11): 807.

https://doi.org/10.1182/blood.V104.11.807.807

Published: 2004

Journal Articles

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

E. Gonzalez-Barca, PhD, E. Domingo-Domenech, MD, J. Gomez-Codina, MD, F. Capote, MD, E. Flores, MD, J. Briones, PhD, A. Salar, PhD, C. Panizo, MD, C. Montalban, PhD, J. M. Ribera, PhD, D. Caballero, PhD, A. Muñoz, MD, L. Gallur, MD, M.A. Canales, MD, P. Fernandez, MD, M. Encuentra, A. Fernandez de Sevilla, PhD

Blood (2004) 104 (11): 1406.

https://doi.org/10.1182/blood.V104.11.1406.1406

Published: 2004

Journal Articles

Rituximab and Stem Cell Transplantation Produces Durable Remissions in Mantle Cell Lymphoma.

Blood (2004) 104 (11): 1390.

https://doi.org/10.1182/blood.V104.11.1390.1390

Published: 2004

Journal Articles

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

J.F. San Miguel, A. Martı́nez, A. Macedo, M.B. Vidriales, C. López-Berges, M. González, D. Caballero, M.A. Garcı́a-Marcos, F. Ramos, J. Fernández-Calvo, M.J. Calmuntia, J. Diaz-Mediavilla, A. Orfao

Blood (1997) 90 (6): 2465–2470.

https://doi.org/10.1182/blood.V90.6.2465

Published: 1997

NARROW

The Roel of High Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) In PATIENTS with POEMS SYNDROME: A Retrospective study of the MM Subcommittee of the Chronic Leukemia Working Party of the EBMT,

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

R-ESHAP as Salvage Therapy for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Spanish GEL-TAMO Multicenter Study.

Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Diffuse Large-B Cell Lymphoma (DLBCL): A Spanish Multicenter Study.

Autologous Stem Cell Transplantation and Rituximab for Mantle Cell Lymphoma.

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

Rituximab and Stem Cell Transplantation Produces Durable Remissions in Mantle Cell Lymphoma.

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only